BBC News5 sa önceSalud
UK Regulator Approves Human Trials for New Ebola Vaccine Developed by Oxford University
En resumen
- Human trials for a new Ebola vaccine, developed by Oxford University using technology similar to the COVID-19 vaccine, have been approved by UK regulators.
- The vaccine targets the Bundibugyo species of Ebola, responsible for an ongoing epidemic in the Democratic Republic of the Congo.
Resumen generado por IA
Tamaño de fuente
Human trials for a new Ebola vaccine, developed by Oxford University using technology similar to the COVID-19 vaccine, have been approved by UK regulators. The vaccine targets the Bundibugyo species of Ebola, responsible for an ongoing epidemic in the Democratic Republic of the Congo.
Temas relacionados
This article was originally published by BBC News.
